Company Details
| Sector | PHARMACEUTICALS |
| Address | |
| Auditor | |
| Registrar | |
| Website | |
| Fiscal Year | |
| Details |
Description
Company Announcements
| Date/Time | Announcement |
|---|---|
| 29/10/2024 14:51:27 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,204.909 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2024 EPS = 124.93 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,149.594 |
| 23/08/2024 16:51:56 | (UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,410.669 BOOK CLOSURE FROM 05/09/2024 BOOK CLOSURE TO 06/09/2024 (UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 826.003 DIVIDEND = 250%(I) EPS = 85.64 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2024 |
| 24/04/2024 16:06:15 | PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 658.718 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/12/2023 EPS = 34.82 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 335.816 |
| 22/02/2024 16:37:41 | ANNUAL GENERAL MEETING HELD ON 08/04/2024 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2023 DIVIDEND = 300%(F) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 916.099 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 360.807 EPS = 37.41 BOOK CLOSURE FROM 02/04/2024 BOOK CLOSURE TO 08/04/2024 |